Literature DB >> 25407094

The trajectory of cognitive decline in the pre-dementia phase in memory clinic visitors: findings from the 4C-MCI study.

R Hamel1, S Köhler1, N Sistermans2, T Koene3, Y Pijnenburg2, W van der Flier2, P Scheltens2, P Aalten1, F Verhey1, P J Visser1, I Ramakers1.   

Abstract

BACKGROUND: We investigated the course of decline in multiple cognitive domains in non-demented subjects from a memory clinic setting, and compared pattern, onset and magnitude of decline between subjects who progressed to Alzheimer's disease (AD) dementia at follow-up and subjects who did not progress.
METHOD: In this retrospective cohort study 819 consecutive non-demented patients who visited the memory clinics in Maastricht or Amsterdam between 1987 and 2010 were followed until they became demented or for a maximum of 10 years (range 0.5-10 years). Differences in trajectories of episodic memory, executive functioning, verbal fluency, and information processing speed/attention between converters to AD dementia and subjects remaining non-demented were compared by means of random effects modelling.
RESULTS: The cognitive performance of converters and non-converters could already be differentiated seven (episodic memory) to three (verbal fluency and executive functioning) years prior to dementia diagnosis. Converters declined in these three domains, while non-converters remained stable on episodic memory and executive functioning and showed modest decline in verbal fluency. There was no evidence of decline in information processing speed/attention in either group.
CONCLUSIONS: Differences in cognitive performance between converters to AD dementia and subjects remaining non-demented could be established 7 years prior to diagnosis for episodic memory, with verbal fluency and executive functioning following several years later. Therefore, in addition to early episodic memory decline, decline in executive functions may also flag incident AD dementia. By contrast, change in information processing speed/attention seems less informative.

Entities:  

Keywords:  neuropsychology

Mesh:

Year:  2014        PMID: 25407094     DOI: 10.1017/S0033291714002645

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  16 in total

1.  Early identification of MCI converting to AD: a FDG PET study.

Authors:  Marco Pagani; Flavio Nobili; Silvia Morbelli; Dario Arnaldi; Alessandro Giuliani; Johanna Öberg; Nicola Girtler; Andrea Brugnolo; Agnese Picco; Matteo Bauckneht; Roberta Piva; Andrea Chincarini; Gianmario Sambuceti; Cathrine Jonsson; Fabrizio De Carli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-29       Impact factor: 9.236

2.  Diffusion Tensor Imaging Predictors of Episodic Memory Decline in Healthy Elders at Genetic Risk for Alzheimer's Disease.

Authors:  Melissa A Lancaster; Michael Seidenberg; J Carson Smith; Kristy A Nielson; John L Woodard; Sally Durgerian; Stephen M Rao
Journal:  J Int Neuropsychol Soc       Date:  2016-11       Impact factor: 2.892

3.  Identification of Successful Cognitive Aging in the Alzheimer's Disease Neuroimaging Initiative Study.

Authors:  Feng V Lin; Xixi Wang; Rachel Wu; George W Rebok; Benjamin P Chapman
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Using Mixture Modeling to Construct Subgroups of Cognitive Aging in the Wisconsin Longitudinal Study.

Authors:  Sara M Moorman; Emily A Greenfield; Kyle Carr
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2021-09-13       Impact factor: 4.077

5.  Neurocognitive functioning is associated with functional independence in newly diagnosed patients with temporal lobe glioma.

Authors:  Kyle R Noll; Mariana E Bradshaw; Jeffrey S Weinberg; Jeffrey S Wefel
Journal:  Neurooncol Pract       Date:  2017-11-19

6.  Validation of Taiwan Performance-Based Instrumental Activities of Daily Living (TPIADL), a Performance- Based Measurement of Instrumental Activities of Daily Living for Patients with Vascular Cognitive Impairment.

Authors:  Hui-Mei Chen; Hsiu-Fen Lin; Mei-Feng Huang; Chun-Wei Chang; Yi-Chun Yeh; Yi-Ching Lo; Cheng-Fang Yen; Cheng-Sheng Chen
Journal:  PLoS One       Date:  2016-11-16       Impact factor: 3.240

Review 7.  On the path to 2025: understanding the Alzheimer's disease continuum.

Authors:  Paul S Aisen; Jeffrey Cummings; Clifford R Jack; John C Morris; Reisa Sperling; Lutz Frölich; Roy W Jones; Sherie A Dowsett; Brandy R Matthews; Joel Raskin; Philip Scheltens; Bruno Dubois
Journal:  Alzheimers Res Ther       Date:  2017-08-09       Impact factor: 6.982

8.  24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial.

Authors:  Hilkka Soininen; Alina Solomon; Pieter Jelle Visser; Suzanne B Hendrix; Kaj Blennow; Miia Kivipelto; Tobias Hartmann
Journal:  Lancet Neurol       Date:  2017-10-30       Impact factor: 44.182

9.  The Effect of Task-Irrelevant Fearful-Face Distractor on Working Memory Processing in Mild Cognitive Impairment versus Healthy Controls: An Exploratory fMRI Study in Female Participants.

Authors:  Amer M Burhan; Udunna C Anazodo; Jun Ku Chung; Amanda Arena; Ariel Graff-Guerrero; Derek G V Mitchell
Journal:  Behav Neurol       Date:  2016-02-01       Impact factor: 3.342

10.  Beta-amyloid and Cortical Thickness Reveal Racial Disparities in Preclinical Alzheimer's Disease.

Authors:  Ian M McDonough
Journal:  Neuroimage Clin       Date:  2017-09-21       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.